Enrico Maria Pogliani

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry

Guido Finazzi, Vincenzo Brancaccio, Marco Moia et al. · The American Journal of Medicine · 1996 · 435 citations

Medicine, Hematology, Internal Medicine +17

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani et al. · Blood · 2009 · 430 citations · Full text

Medicine, Oncology, Chemotherapy +13

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Carlo Gambacorti‐Passerini, Laura Antolini, François‐Xavier Mahon et al. · JNCI Journal of the National Cancer Institute · 2011 · 428 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +15

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Rocco Piazza, Simona Valletta, Nils Winkelmann et al. · Nature Genetics · 2012 · 425 citations · Full text

Medicine, Genetics, Oncology +11

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi et al. · New England Journal of Medicine · 2011 · 422 citations · Full text

Medicine, Oncology, Chemotherapy +11